Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Maris

Showing results (111-120 of 458) with videos related to

Pageof 46
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Prominent microvascular proliferation in clinically aggressive neuroblastomaRadhika Peddinti, Rana Zeine, Dragos Luca, et al.
The Journal of Bone and Joint Surgery. American Volume|December 1, 1988
The bioenergetics of preservation of limbs before replantation. The rationale for intermediate hypothermiaA A Sapega, R B Heppenstall, D P Sokolow, et al.
Journal of Cellular Biochemistry|October 4, 2005
Anticancer effects of the novel 1alpha, 25-dihydroxyvitamin D3 hybrid analog QW1624F2-2 in human neuroblastomaC Damodar Reddy, Ratnakar Patti, Asha Guttapalli, et al.
Bioinformatics (Oxford, England)|May 21, 2005
CGHAnalyzer: a stand-alone software package for cancer genome analysis using array-based DNA copy number dataAdam A Margolin, Joel Greshock, Tara L Naylor, et al.
Cancer Research|April 3, 2003
ID2 expression is not associated with MYCN amplification or expression in human neuroblastomasQun Wang, George Hii, Suzanne Shusterman, et al.
Cancer Research|October 15, 1995
Significance of chromosome 1p loss of heterozygosity in neuroblastomaJ M Maris, P S White, C P Beltinger, et al.
Cancer Research|November 9, 2012
Combination therapy targeting the Chk1 and Wee1 kinases shows therapeutic efficacy in neuroblastomaMike R Russell, Kirill Levin, JulieAnn Rader, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
IMMUNOTAR - Integrative prioritization of cell surface targets for cancer immunotherapyRawan Shraim, Brian Mooney, Karina L Conkrite, et al.
Journal of the National Cancer Institute|February 23, 2019
Differences in Genomic Profiles and Outcomes Between Thoracic and Adrenal NeuroblastomaDerek A Oldridge, Bao Truong, Douglas Russ, et al.
Journal of the National Cancer Institute|February 8, 2022
Identification of Mitochondrial DNA Variants Associated With Risk of NeuroblastomaXiao Chang, Yichuan Liu, Joseph Glessner, et al.
Pageof 46

Showing results (111-120 of 458) with videos related to

Sort By:
Pageof 46
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Prominent microvascular proliferation in clinically aggressive neuroblastomaRadhika Peddinti, Rana Zeine, Dragos Luca, et al.
The Journal of Bone and Joint Surgery. American Volume|December 1, 1988
The bioenergetics of preservation of limbs before replantation. The rationale for intermediate hypothermiaA A Sapega, R B Heppenstall, D P Sokolow, et al.
Journal of Cellular Biochemistry|October 4, 2005
Anticancer effects of the novel 1alpha, 25-dihydroxyvitamin D3 hybrid analog QW1624F2-2 in human neuroblastomaC Damodar Reddy, Ratnakar Patti, Asha Guttapalli, et al.
Bioinformatics (Oxford, England)|May 21, 2005
CGHAnalyzer: a stand-alone software package for cancer genome analysis using array-based DNA copy number dataAdam A Margolin, Joel Greshock, Tara L Naylor, et al.
Cancer Research|April 3, 2003
ID2 expression is not associated with MYCN amplification or expression in human neuroblastomasQun Wang, George Hii, Suzanne Shusterman, et al.
Cancer Research|October 15, 1995
Significance of chromosome 1p loss of heterozygosity in neuroblastomaJ M Maris, P S White, C P Beltinger, et al.
Cancer Research|November 9, 2012
Combination therapy targeting the Chk1 and Wee1 kinases shows therapeutic efficacy in neuroblastomaMike R Russell, Kirill Levin, JulieAnn Rader, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
IMMUNOTAR - Integrative prioritization of cell surface targets for cancer immunotherapyRawan Shraim, Brian Mooney, Karina L Conkrite, et al.
Journal of the National Cancer Institute|February 23, 2019
Differences in Genomic Profiles and Outcomes Between Thoracic and Adrenal NeuroblastomaDerek A Oldridge, Bao Truong, Douglas Russ, et al.
Journal of the National Cancer Institute|February 8, 2022
Identification of Mitochondrial DNA Variants Associated With Risk of NeuroblastomaXiao Chang, Yichuan Liu, Joseph Glessner, et al.
Pageof 46